64 citations
- University of MichiganUS5 papers
- Eli Lilly (United States)US3 papers
- AbbVie (Japan)1 paper
- Amgen (United States)US1 paper
- Berkeley CollegeUS1 paper
- Boston UniversityUS1 paper
- Bristol-Myers Squibb (United States)US1 paper
- CSL (Switzerland)CH1 paper
- CSL (United States)US1 paper
- Day Kimball HealthcareUS1 paper
- Eli Lilly (Canada)CA1 paper
- Eli Lilly (Singapore)SG1 paper
Showing 2018Show all
2 papers · 1 filter
math.ST2018★ 2 cited
High Dimensional Robust Inference for Cox Regression Models
Shengchun Kong, Zhuqing Yu, Xianyang Zhang +1
We consider high-dimensional inference for potentially misspecified Cox proportional hazard models based on low dimensional results by Lin and Wei [1989]. A de-sparsified Lasso est…
stat.ME2018★ 20 cited
Sample size considerations for comparing dynamic treatment regimens in a sequential multiple-assignment randomized trial with a continuous longitudinal outcome
Nicholas J. Seewald, Kelley M. Kidwell, Inbal Nahum-Shani +3
Clinicians and researchers alike are increasingly interested in how best to personalize interventions. A dynamic treatment regimen (DTR) is a sequence of pre-specified decision rul…